Compare Noble Corporation plc (NE) vs TransMedics Group Inc (TMDX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Noble Corporation plc vs TransMedics Group Inc — how do they compare? Noble Corporation plc trades at $45.83 (market cap $7.33B), while TransMedics Group Inc trades at $85.89 (market cap $3.06B). The key difference: Noble Corporation plc is far larger — about 2.4× TransMedics Group Inc's market cap, and Noble Corporation plc pays a 4.36% dividend while TransMedics Group Inc pays none. Which is the better fit depends on your goals.
| NE | TMDX | |
|---|---|---|
Market Cap | $7.33B | $3.06B |
Sector | Technology | Technology |
52-Week High | $54.37 | $150.42 |
52-Week Low | $26.70 | $61.99 |
Enterprise Value | $8.76B | $3.46B |
Dividend Yield | 4.36% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Noble Corporation (NE) trades at $45.89, up 0.61% on the day, with a bullish technical signal from moving averages and a consensus analyst price target of $46.00. Recent earnings show mixed quarterly results, with a Q1 2026 beat but Q2 and Q4 2025 misses, while annual revenue declined to $3.1 billion in 2026 from $3.3 billion in 2025, and net income fell to $150 million. The company maintains positive cash flow from operations and announced a $0.50 dividend payable in September 2026.
Outlook is cautious due to earnings volatility and revenue contraction, offset by strong cash generation and analyst support. Key risks include ongoing legal investigations and competitive pressures in the offshore drilling sector. The stock presents a balanced opportunity with moderate upside to the price target, but investors should monitor earnings consistency and legal developments.
TransMedics Group (TMDX) trades at $88.27, down 1.9% on the day, with a bullish technical signal from moving averages but mixed earnings results. The company reported strong revenue growth to $605.49M in 2025, with a net income margin of 22.69%, though profitability is expected to moderate in 2026. Recent news highlights ongoing legal investigations into fiduciary duties alongside positive coverage of growth initiatives in kidney transplantation and European expansion.
The stock presents a growth opportunity with analyst consensus pointing to a $99.57 price target, but risks include margin pressure from heavy investments and legal uncertainties. Earnings misses in recent quarters and a projected decline in net income for 2026 warrant caution, though institutional interest remains with a bullish rating from 69% of analysts.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Noble Corporation plc
Noble Corporation plc is a leading offshore drilling contractor for the oil and gas industry. The company owns and operates a high-specification fleet of mobile offshore drilling units, including drillships and semi-submersibles, that are used for exploration and production activities in deepwater and harsh environments worldwide. Noble focuses on providing safe, efficient, and reliable drilling services to major and independent oil and gas companies globally.
Read more on NE →About TransMedics Group Inc
TransMedics is a pioneering medical technology company that is disrupting the organ transplant market with its Organ Care System (OCS™). By replacing traditional cold storage with portable warm perfusion, the OCS maintains donor organs in a near-physiologic state, allowing for continuous assessment and optimization. Through its National OCS Program (NOP™), TransMedics provides an end-to-end clinical and logistics solution, including a dedicated aviation fleet, to maximize the utilization of donor organs and improve patient outcomes.
Read more on TMDX →
